AMGN•benzinga•
Amgen Says SPROUT Data Show Otezla Resulted In 'Significant Improvements' In Measures Of Moderate To Severe Plaque Psoriasis At Week 16 Compared With Placebo In Children Ages 6-17
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 8, 2022 by benzinga